Skip to content

HIFEM versus Mobile aided PFMT for Female Stress Urinary Incontinence: A randomized Controlled Trial

HIFEM versus Mobile aided PFMT for Female Stress Urinary Incontinence: A randomized Controlled Trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20250411003
Enrollment
64
Registered
2025-04-11
Start date
2024-09-11
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female stress urinary Incontinence HIFEM, High Intensity Focused Electro-Magnetic, pelvic floor muscle training , stress urinary incontinent

Interventions

High Intensity Focused Electro-Magnetic (HIFEM), EMSELLA, is an electromagnetic field produced by a flat spiral-shape coil which reaches intensity up to 2.5 Tesla, similar strength to MRI. The coil is
Experimental Device,Active Comparator Device
HIFEM group,Mobile application based PFMT group

Sponsors

Faculty if Medicine Ramathibodi, Hospital Mahidol University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Female who diagnosed of SUI predominate (mild to moderate severity) by ICIQ-UI SF score plus 1-hour pad test > 1 g but less than 50 g 2. Willing to follow the research protocol follow up 3. Willing to sign informed consent 4. Age more than 18 years old 5. Able to communicate in Thai and use the mobile application

Exclusion criteria

Exclusion criteria: 1. Previous treatment for SUI 2. Suspected urethral or vesical fistula 3. Urinary tract infection or hematuria 4. Pregnancy or lactation 5. Cardiac pacemaker or implanted metallic devices 6. VTE or blood coagulation disorder 7. Severe uncontrolled disease e.g., malignancy 8. Unwilling to follow the research protocol follow up 9. Withdraw from study

Design outcomes

Primary

MeasureTime frame
SUI symptoms Before treatment, after treatment, 3 months after treatment 1 hour pad test, perineometry

Secondary

MeasureTime frame
Quality of life Before treatment, after treatment, 3 months after treatment ICIQ-UI SF score, IIQ-7 score

Countries

Thailand

Contacts

Public ContactNichanan Archanan

Faculty of Medicine Ramathibodi Hospital, Mahidol University

nichanan.archanan@gmail.com0896829080

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026